|
HS Code |
747130 |
| Iupac Name | 3-bromo-pyrazolo[1,5-a]pyridine-5-carboxylic acid |
| Molecular Formula | C8H5BrN2O2 |
| Molecular Weight | 241.045 g/mol |
| Cas Number | 944904-74-5 |
| Appearance | White to off-white solid |
| Solubility | Slightly soluble in DMSO, DMF |
| Smiles | C1=CC2=NN=C(C2=NC1Br)C(=O)O |
| Inchi | InChI=1S/C8H5BrN2O2/c9-6-1-2-7-10-11-4-5(12)8(7)3-6/h1-4H,(H,12,13) |
| Pubchem Cid | 52957556 |
| Storage Conditions | Store at 2-8°C, keep dry and away from light |
As an accredited pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains 5 grams of pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-, sealed in an amber glass bottle. |
| Container Loading (20′ FCL) | 20′ FCL loading of 3-Bromo-pyrazolo[1,5-a]pyridine-5-carboxylic acid ensures safe, secure, and efficient bulk chemical transportation. |
| Shipping | **Shipping Description:** Pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- is shipped in airtight, chemically-resistant containers. It is handled as a laboratory chemical, transported compliant with relevant chemical safety and regulatory standards. Shipping includes appropriate labeling, cushioning, and temperature control (if required), ensuring safe delivery and minimal risk of contamination or degradation. |
| Storage | **Storage Description:** Store **pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-** in a tightly closed container in a cool, dry, and well-ventilated area. Protect from light, moisture, and sources of ignition. Keep away from incompatible substances such as strong oxidizers. Use in a chemical fume hood and wear appropriate personal protective equipment when handling. Store in accordance with local regulations. |
| Shelf Life | Pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- typically has a shelf life of 2–3 years when stored properly in cool, dry conditions. |
|
Purity 98%: pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- with 98% purity is used in pharmaceutical intermediate synthesis, where it ensures high yield and reproducibility of active compounds. Melting point 210°C: pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- with a melting point of 210°C is used in organic electronics research, where thermal stability enhances material durability. Molecular weight 253.04 g/mol: pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- at a molecular weight of 253.04 g/mol is used in fragment-based drug discovery, where precise segment selection accelerates lead optimization. Particle size < 10 µm: pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- featuring particle size less than 10 µm is used in fine chemical formulations, where improved dispersion improves reaction efficiency. Stability at 40°C: pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- demonstrating stability at 40°C is used in analytical method development, where extended shelf-life supports long-term study reliability. |
Competitive pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every chemical tells a story – not from certificates or brochures, but from what’s actually happening in the reactors. Pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-, is one of those compounds that brings a real challenge to the lab, and we know it inside out because we’re there for every step, from raw input to purified solid on the drying trays. Our involvement isn’t just technical; it’s hands-on, batch after batch. Working with this molecule through all its stages, we stay close to process irregularities and improvements, not just ticking checkboxes but looking for what really works in practice and what causes headaches downstream.
Pyrazolo[1,5-a]pyridine-5-carboxylic acid, with a bromo group at position 3, walks a fine line in the synthetic world. Unlike basic intermediates, this structure demands high control during both the bromo installation and the pyridine chemistry. For our team, that’s where process know-how really pays off. Blending the heterocycle at the core with the precise carboxyl and bromo orientation means dealing with tricky selectivity. We don’t just trust the literature or outsource the hard parts. Each reaction run starts only after equipment is recalibrated and raw material purity is checked above 99%. Over the years, we found that even a percent’s slip during bromo introduction pushes side product profile up, which nobody wants to deal with in their next synthesis step.
All this talk about purity reaches way beyond an analytical ticket. Testing purity by HPLC and NMR isn’t a paperwork drill here; it’s tightly connected to customer outcomes. Advances in process optimization have made it possible to reliably keep byproducts below 0.2% by area, with a focus on keeping 3,7-dibromo analogues in check. It takes extra work sorting out the pH during workup and being ready to re-extract if any signal drifts from the main peak. We’ve seen what happens when someone cuts corners – batch-to-batch unpredictability jumps, and that only leads to wasted downstream intermediates or worse, failed scale-ups. We’d rather bite the bullet and run second recrystallizations than ship anything that looks marginal.
This isn’t a compound that sits around on a warehouse shelf. For most buyers, 3-bromo-pyrazolo[1,5-a]pyridine-5-carboxylic acid slots into pharma research pipelines, especially as a core building block in kinase inhibitor candidates and related biologically active molecules. Over time, we’ve seen clients expand its use across several custom synthesis tracks, leveraging its reactive positions for downstream Suzuki and Buchwald-Hartwig couplings. Some even push past obvious transformations to novel diversification on the heterocycle – a testament to what solid, reproducible sourcing empowers in the hands of skilled medicinal chemists.
Process chemists care about how the compound dissolves and behaves during coupling, especially concerning metal-catalyzed steps. We saw inconsistent results a few years back when a customer relied on off-brand imports for this material; disproportionate signal loss and batch rework all traced back to micro-impurities in crude extracts. It’s not hype to say that a cleaner starting reagent reduces wasted hours and raw materials at the next step.
Moving from kilo scale right up to the pilot plant is a different world than benchtop runs. Anyone who has stood over a drum of heterocyclic acid during transfer knows the importance of dry handling and quick packaging. Atmospheric moisture uptake leads to caking, which can botch not just storage but accurate weighing during formulation. By working up the compound under carefully controlled conditions, ensuring thorough vacuum drying, and storing under nitrogen, we prevent the stickiness and inconsistency seen with less controlled batches. Time and again, customers running late-stage discovery chemistry come back for packaging in smaller, moisture-stable aliquots, as this keeps performance steady, even after months on the shelf.
Dust and static charge can give headaches in larger plants, especially in dry winter climates. Antistatic liners and careful grounding during transfer are not theoretical concerns – they’ve prevented several near misses that could have resulted in cross-contamination or material loss. These little details are learned from years of practical exposure, not just from safety training manuals.
There’s no real shortcut to making this intermediate work for every customer. Wide variability shows up in the market, even in simple things like how tightly the product is sieved, or the real particle size distribution (not just d90 printed in a certificate). We handcheck quality at different stages, not just after the final filtration. Anyone scaling up cross-coupling or running QbD projects notices that if the acid is off in granularity or water content, solubility tanks or filtration gets bogged down. We’ve had customers send in their process residues for troubleshooting and traced issues back to uneven batches from different suppliers that handled isolation too carelessly.
Our crew made it a habit to sample every tenth kilo at random during packing and double back through the analytical panel. That tight loop between production and quality control lets us catch roll-up issues before they slip downstream, including minor contamination from production equipment, which can be harder to spot in a paper audit than people think.
We’ve never bought into the myth that bigger means better in heterocycle manufacturing. Rather, we developed a compact synthesis line dedicated solely to this class of intermediates, running it without overlap with sulfur-based products, which are unforgiving in cross-contamination. The discipline needed to keep everything clean and traceable drives home real trust, especially when a customer moves from gram to pilot runs.
Problems don’t always start during the reaction. Several pharmaceutical partners have called us in on troubleshooting when standard Suzuki couplings with this acid stalled or yielded extra side products. A common culprit: non-volatile residues (surfactants, oils, or traces of mother liquor) missed during improper washing or isolation stages. On one occasion, a customer received a batch from an unknown source that left a ghostly haze in their final product – their screening runs flagged heavy metals at low ppm. We reviewed their data and traced the batch’s history, which confirmed lax quality and mixing of batch fragments.
In our workflow, we go back to additional organic wash steps. It costs more time and solvent, but we’ve yet to see a return batch with those haze issues after running the extra cleaning cycle. Process discipline pays off: avoiding excess retesting, waste of reagents and, above all, lost time in a fast-moving drug discovery environment.
The global fine chemicals market doesn’t treat all intermediates equally. Some sources advertise fast lead times but don’t control for product consistency and traceability. Our experience says product movement is important, but consistency and the story behind each batch matter most. Professionals running lead optimization know the cost of redoing a step just from bad supplier reliability. We’ve spent years tuning our logistics so that we can maintain tight control from synthesis to shipment, using temperature-monitored shipping for sensitive lots and checking cartons for integrity even during final export inspection.
Our crew doesn’t just push paperwork updates. We regularly revalidate the manufacturing pathway with full analytical re-qualification, looking for new trace-level contaminants not covered before. We think of this as a feedback-driven process, not a box-ticking formality. Tight feedback loops with clients inform changes and drive work on better purification stages or packaging improvements. Each challenge in the field prompts us to fix not just the immediate bug but the upstream weak spot, so next time the problem doesn’t even show up.
In regulated markets, it doesn’t pay to skimp on compliance and documentation. For most researchers interested in pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-, what matters is confidence in the supplied data and the openness to share production traceability. About once a quarter, we field bespoke requests for extended impurity profiles or nonstandard solvent residual panels for regulatory submission. We keep extensive records, including full batch genealogy and reprocessing logs, so these data requests are answered by opening our files, not by post-hoc testing.
Some regulatory trends show tightening limits on potential genotoxic impurities and solvent residues. We respond by extending our analytical checks year-on-year and providing new CoA formats matching current regulatory language. In conversations with researchers preparing for IND submissions, we supply not only what’s legally required but what will stand up to full regulatory scrutiny. As we see more complex downstream synthesis hitting the clinic, we know our commitment to thorough record-keeping and raw material vetting has to keep pace.
Every time a customer or formulation chemist picks up a batch from our shop, we hear back about some real-world performance point we hadn’t considered in development. For one partner scaling to multi-kilo lots, the difference between quick-dissolving powder versus slightly aggregated material changed their process times by hours per batch. Feedback like this shapes how we finish our product—sticking with proven drying cycles and careful granulation, rather than chasing marginal cost savings. That’s not something a spreadsheet can optimize; it comes from actually talking and listening to the people using what we make.
Another long-running partner requested custom packaging after running into issues with static during winter production, which we solved by providing pre-dosed, antistatic bags. Small requests like these often translate to far fewer errors or process slowdowns at large scale. We learned not to underestimate the value of these tweaks, and we offer flexible solutions without compromising batch-to-batch consistency.
We take personal responsibility for environmental controls, not just for regulatory optics, but as a core part of our operations. Throughout the production of pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-, our team actively controls effluent and waste gas release. Our plant includes active carbon traps and secondary containment for all halogenated waste streams. We learned early on that prevention beats post-incident cleanup both in cost and in standing with local communities.
Training new staff doesn’t finish at standard SOPs. We run hands-on workshops and regular review sessions to keep everyone sharp on unexpected process anomalies, spills, or equipment faults. Years of working with this and similar bromo-heterocycles sharpened our awareness of exposure limits and proper use of engineering controls. Tighter workplace monitoring means we can drive exposure levels down and keep a clean, safe environment both in the plant and for the teams handling finished goods.
Nothing about the market for advanced building blocks stands still for long. We constantly review new synthetic routes, seeking ways to lower waste while raising recovery, and evaluate greener alternatives for both solvents and reagents. Recently, we’ve started work to pilot a revised oxidation process that reduces generation of halogenated byproducts. While it sounds simple in a cost analysis, achieving reproducible results batch after batch takes real attention and patience, often working through unexpected issues with intermediates. We rely on cross-team review, hands-on pilot bench work, and client feedback before bringing any new process change fully online.
Technical advances can mean small changes, like refining an existing purification gradient, or bigger shifts like adopting second-generation catalysts. Each tweak goes through full scale-up validation. It might slow down deployment, but we prefer making gains in reliability and sustainability over just increasing output.
Chemical manufacturing, especially with specialized structures like pyrazolo[1,5-a]pyridine-5-carboxylic acid, 3-bromo-, doesn’t reward shortcuts or generic thinking. Our practice emerges from years of focusing on quality control and real-world user feedback, reinforced by robust safety and environmental protocols. Customers can rely on a product made with attentive care, tuned over hundreds of batches, and backed by an experienced team ready to address unique process needs. Sharing practical details and listening carefully to user experience, we continue evolving alongside our partners, always driving for better solutions in both process and product.